Elanco Animal Health (ELAN) IPO Opens 34% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Elanco Announces Pricing of Initial Public Offering
September 19, 2018 5:31 PM EDTGREENFIELD, Ind.--(BUSINESS WIRE)-- Regulatory News:
Elanco Animal Health Incorporated, a subsidiary of Eli Lilly and Company (NYSE: LLY), announced today the pricing of its initial public offering (IPO) of 62.9 million shares of its common stock at a price to the public of $24.00 per share. The shares are expected to begin trading on the New York Stock Exchange (NYSE) on September 20, 2018 under the ticker symbol ELAN. The offering is expected to close on September 24, 2018, subject to customary closing conditions.
Elanco has granted the underwriters a 30-day option to purchase up to... More
Elanco Announces Pricing of Initial Public Offering
September 19, 2018 5:12 PM EDTGREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated, a subsidiary of Eli Lilly and Company (NYSE: LLY), announced today the pricing of its initial public offering (IPO) of 62.9 million shares of its common stock at a price to the public of $24.00 per share. The shares are expected to begin trading on the New York Stock Exchange (NYSE) on September 20, 2018 under the ticker symbol ELAN. The offering is expected to close on September 24, 2018, subject to customary closing conditions.
Elanco has granted the underwriters a 30-day option to purchase up to 9.435 million... More
